Welcome to our dedicated page for Barrick Mining news (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barrick Mining stock.
Barrick Mining Corporation reports developments tied to its global gold and copper mining, exploration and development portfolio. Company news commonly covers operating and financial results, mine and project updates, technical and governance matters, and capital allocation actions for common shares that trade on the NYSE under B and on the TSX under ABX.
Recurring updates include quarterly results releases, dividend declarations, share repurchase authorizations, annual meeting materials and changes in executive or board oversight. Barrick also reports on its gold assets in North America and other mining jurisdictions, including disclosures connected to major mines, development projects, reserves, production, costs, cash flow and responsible mining obligations.
BioArctic (NASDAQ Stockholm: BIOA B) announced that partner Eisai will present extensive new clinical and real-world evidence on lecanemab (Leqembi) at the AAIC 2026 conference in London, July 12–15. Highlights include subcutaneous dosing, long-term and maintenance use, at-home administration, and multiple real-world and preclinical Alzheimer’s studies.
TransAct Technologies (Nasdaq: TACT) appointed Troy Ingianni as Chief Financial Officer, effective July 1, 2026. Ingianni has over 25 years of financial leadership experience at global public and private companies, most recently serving as Vice President, Global Controller and Chief Accounting Officer at Barnes Group.
He succeeds Steven DeMartino. Previously announced successor Robert Campbell withdrew his candidacy for personal reasons. Management highlights Ingianni’s technical accounting, SEC reporting, and global leadership experience as important to scaling the BOHA! SaaS platform and strengthening recurring, higher-margin revenue.
Crawford (NYSE:A) announced a leadership transition in its Middle East operations and new senior hires in the UAE.
Regional director Vic Noble will retire at the end of July 2026. Christopher Wylie becomes regional director from 22 June 2026, and senior adjusters Chris Burley and Steve Smith join in the UAE.
BioArctic (NASDAQ STOCKHOLM:B) announced a research and collaboration agreement with Eli Lilly to combine BioArctic's BrainTransporter technology with an undisclosed Lilly neurodegeneration drug candidate. BioArctic receives USD 30 million upfront, is eligible for up to USD 770 million in milestones, plus tiered mid-single digit royalties.
Lilly will handle global development and commercialization. This is BioArctic's fourth BrainTransporter collaboration, while it retains platform rights outside the four deals. The project uses an investigational agent, with no assurance of clinical success or regulatory approval.
Hexagon (NYSE:B) released global Robot Generation survey findings on attitudes toward robots at work and in daily life. Adults and children favour robots for physical, repetitive, and hazardous tasks, but strongly prefer humans for caregiving and roles needing empathy or accountability.
Most respondents support robots in factories and warehouses over hospitals or classrooms, and 86% of adults want clear rules on robot use. Children are more likely than adults to see robots as full colleagues, indicating a generational shift in workplace expectations.
Barrick Mining (NYSE:B) released its 2025 Sustainability Report and performance data, highlighting safety, community, and environmental metrics.
Key data include a 60% reduction in total recordable injury frequency rate since 2020, 28% fewer lost-time injuries year-on-year, $7.1 billion in host-country procurement, $62 million in community initiatives, water reuse above an 80% target, and an maintained ‘A’ rating on its Sustainability Scorecard.
BioArctic (Nasdaq Stockholm: BIOA B) issued 5,000 Class B shares in May 2026 through exercise of 5,000 stock options from the 2019/2028 program. As of May 29, 2026, BioArctic has 88,724,485 shares outstanding and 218,324,449 votes in total.
The share capital comprises 74,324,489 listed Class B shares and 14,399,996 unlisted Class A shares. Each A share carries ten votes and each B share one vote.
BioArctic (Nasdaq Stockholm: BIOA B) held its AGM on 28 May 2026 and approved the 2025 income statement and balance sheet, a dividend of SEK 2 per share with record date 1 June 2026, and discharge of the board and CEO.
Shareholders re-elected six directors, elected two new members, and re-elected the chair. The AGM authorised the board to issue new shares, warrants and convertibles of up to 10% of share capital, adopted a three-year PSU incentive program of up to 235,000 units with related hedging, and updated senior executive remuneration guidelines.
Crawford (NYSE:A), a global claims management and outsourcing provider, marks its 85th anniversary by emphasizing future growth and innovation rather than a retrospective.
The company highlights its evolution from a single Georgia office to a worldwide platform using technology, AI-enabled tools, and data-driven insights across the full claims lifecycle.
BioArctic (NASDAQ Stockholm: B) reported that partner Eisai presented a simulation of potential future Leqembi sales at its Investor Relations Day.
According to Eisai, simulated Leqembi sales reach around JPY 300 billion (≈SEK 17.6 billion) in FY2028, ending March 2029. The disclosure was made under EU Market Abuse Regulation rules.